MIRA PHARMACEUTICALS, INC.·4

Sep 3, 4:05 PM ET

Aminov Erez 4

4 · MIRA PHARMACEUTICALS, INC. · Filed Sep 3, 2025

Insider Transaction Report

Form 4
Period: 2025-08-29
Aminov Erez
DirectorCEO and Chairman
Transactions
  • Award

    Common Stock

    2025-08-29$1.37/sh+62,500$85,625844,700 total
Footnotes (1)
  • [F1]Represents 62,500 RSUs vesting immediately, granted and issued to the Reporting Person from the Issuer's 2022 Omnibus Incentive Plan in connection with the Reporting Person's achievement of certain milestones pursuant to the Reporting Person's Executive Incentive Compensation Plan.

Documents

1 file
  • 4
    ownership.xmlPrimary

    4